Patents by Inventor Emma E. Moore

Emma E. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human calcitonin receptor polypeptides
    Patent number: 5674981
    Abstract: Human calcitonin receptors have been cloned, sequenced and expressed by recombinant means. The receptors and antibodies thereto may be used in screening systems to identify agonists and antagonists of human calcitonin receptors, thereby providing means for treating and preventing abnormal bone resorption, as well as in methods of diagnosis.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: October 7, 1997
    Assignee: ZymoGenetics, Inc.
    Inventors: Emma E. Moore, Paul O. Sheppard, Rolf E. Kuestner
  • Immortalized dendritic cells
    Patent number: 5648219
    Abstract: The present invention provides an immature dendritic cell line derived from p53 growth suppressor gene deficient animals. The immature dendritic cell line may be induced to become an activated dendritic cell line that will stimulate T-cells to proliferate. The cell line is useful for presentation of antigens involved in autoimmune disease and analysis of peptides that produce a T-cell response.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 15, 1997
    Assignee: ZymoGenetics, Inc.
    Inventors: Vivian L. MacKay, Emma E. Moore
  • Recombinant production of human calcitonin receptor polypeptides
    Patent number: 5622839
    Abstract: Human calcitonin receptors have been cloned, sequenced and expressed by recombinant means. The receptors and antibodies thereto may be used in screening systems to identify agonists and antagonists of human calcitonin receptors, thereby providing means for treating and preventing abnormal bone resorption, as well as in methods of diagnosis.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: April 22, 1997
    Assignee: ZymoGenetics, Inc.
    Inventors: Emma E. Moore, Paul O. Sheppard, Rolf E. Kuestner
  • Compositions and methods for stimulating the growth of osteoblasts
    Patent number: 5533836
    Abstract: Methods and compositions for stimulating the growth of osteoblasts are disclosed. A composition comprising platelet derived growth factor and vitamin D is applied to osteoblasts in an amount sufficient to stimulate their growth. The methods may be used to promote the growth of osteoblasts in vitro or to promote the healing of bone defects in vivo.
    Type: Grant
    Filed: March 22, 1995
    Date of Patent: July 9, 1996
    Assignee: ZymoGenetics, Inc.
    Inventor: Emma E. Moore